Supplier info centre > All product innovations
All products forSolvias AGSee also : Supplier info centre |
 |
Technical / white paper
Accelerating Early Drug Development – Reality or Wishful Thinking? - Solvias AG
10-Aug-2009 -
This article focuses on the main aspects to consider when deciding whether or not to outsource chemical and analytical development – including small-scale cGMP API production – to support an early drug development program.
On-Demand Supplier Webinar
Webinar - Meeting the Challenges of Biosimilars Characterization - Solvias AG
16-Jul-2009 -
Generic biologics offer the prospect of cheaper medicines, however exact copies of innovator biological drugs are not possible. A review of analytical requirements, challenges, and the lessons learned will be presented.
Application note
Squeezing Timelines and Development Costs – Solvias' Generic Methods for Biopharmaceutical Analysis - Solvias AG
17-Nov-2009 -
Costly delays owing to the unpredictable behavior of proteins are common during the development of analytical methods for the assessment and control of quality. The article describes how these risks may be minimized using a technology platform of generic methods...
Technical / white paper
Solvias Scientific Magazine – Out now! - Solvias AG
28-Jun-2010 -
Crystallization – Understanding and developing the process
Interview with USP: New method for heavy metals testing <231>
Antibody drug conjugates – Challenges of combining small and large molecules
A new ligand class for asymmetric hydrogenation
Technical / white paper
Solvias Scientific Magazine – out now! - Solvias AG
07-Oct-2010 -
Topics
• Improved product quality via NIR – Real-time monitoring of tablet coating thickness dates
• Biosimilars – A Selection of updates
• High throughput – High science, a prosperous liaison?
• Asymmetric hydrogenation of unfunctionalized olefins• Fiber optic probes – Keeping an eye on processes
Technical / white paper
Extractables and Leachables in Pharma - Solvias AG
06-Jun-2011 -
Extractables and Leachables are a hot topic in pharma. Learn more why this is of concern and how testing for leachables as well as extractables should be conducted.
Technical / white paper
Crystallization – Understanding and developing the process - Solvias AG
28-Nov-2011 -
In order to achieve controlled production of a desired polymorphic form it is essential to primarily understand the product and be intimately familiar with the process. Furthermore, scaling up the crystallization process requires an expert team of experienced scientists working...